Amicogen, Inc.
KOE: 092040.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Piao Zhe
- Employees
- 225
- Headquarters
- Jinju-Si, South Korea
- IPO year
- 2013
- Market cap
- ₩94.8B
- Website
- http://www.amicogen.com
Loading 092040…
Loading profile data…Frequently asked questions about 092040
What does Amicogen, Inc. (092040.KQ) do?
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, chemical, and energy industries. It also provides new bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inosit...
Where does 092040.KQ trade?
Amicogen, Inc. (092040.KQ) trades on the KOSDAQ.
What sector is 092040.KQ in?
Amicogen, Inc. (092040.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Amicogen, Inc.?
Piao Zhe is the chief executive officer of Amicogen, Inc. (092040.KQ).
Where is Amicogen, Inc. headquartered?
Amicogen, Inc. is headquartered in South Korea.
Does 092040.KQ pay a dividend?
Amicogen, Inc. (092040.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 092040.KQ go public?
Amicogen, Inc. (092040.KQ) completed its initial public offering in 2013.